PRTT (Protect Pharmaceutical) Net Income: $-0.02 Mil (TTM As of Jun. 2018)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is Protect Pharmaceutical Net Income?

Protect Pharmaceutical PRTT Net Income is $-0.02 Mil as of Jun. 2018.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Protect Pharmaceutical's Net Income for the three months ended in Jun. 2018 was $-0.00 Mil. Its Net Income for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.02 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Protect Pharmaceutical's Earnings per Share (Diluted) for the three months ended in Jun. 2018 was $-0.00.

Protect Pharmaceutical (OTCPK:PRTT) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Protect Pharmaceutical's Earnings per Share (Diluted) (EPS) for the quarter that ended in Jun. 2018 is calculated as

Earnings per Share (Diluted) (Q: Jun. 2018 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-0.004	-	0)	/	1.358
	=	-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.

Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.

Protect Pharmaceutical Net Income Related Terms

Protect Pharmaceutical Net Income Historical Data

* Premium members only.

The historical data trend for Protect Pharmaceutical's Net Income can be seen below:

Protect Pharmaceutical Net Income Chart

Protect Pharmaceutical Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Net Income

Get a 7-Day Free Trial

-0.02

0.46

-0.64

-0.04

-0.12

Protect Pharmaceutical Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
Net Income	Get a 7-Day Free Trial															-0.10	-0.00	-0.00	-0.00	-0.00

Protect Pharmaceutical Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Protect Pharmaceutical's Net Income for the fiscal year that ended in Dec. 2017 is calculated as

	Net Income		(A: Dec. 2017 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	-0.123	+	0	+	0	+	0
=	-0.12

Protect Pharmaceutical's Net Income for the quarter that ended in Jun. 2018 is calculated as

	Net Income		(Q: Jun. 2018 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	-0.004	+	0	+	0	+	0
=	-0.00

Net Income for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

Frequently Asked Questions Learn more about Net Income →

What does a Net Income of $-0.02 Mil mean?

Protect Pharmaceutical (PRTT) has a Net Income of $-0.02 Mil as of Jun. 2018. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Protect Pharmaceutical and its competitors.

Is Protect Pharmaceutical's Net Income too high?

Protect Pharmaceutical's current Net Income is $-0.02 Mil.

How does Protect Pharmaceutical's Net Income compare to PVEG and FCIC?

Protect Pharmaceutical's Net Income of $-0.02 Mil can be compared against companies in the Transportation industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Income for a Transportation company?

A good Net Income depends on the Transportation industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Income mean?

A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Protect Pharmaceutical and its competitors. Protect Pharmaceutical's current Net Income is $-0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Protect Pharmaceutical stock overvalued right now?

Protect Pharmaceutical (PRTT) has a current Net Income of $-0.02 Mil. The current Net Income is $-0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Income calculated?

Net Income is calculated from a company's financial statements. For Protect Pharmaceutical (PRTT), the current Net Income is $-0.02 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Protect Pharmaceutical Business Description

Industry Industrials Transportation

Comparable Companies TSXV:PMO.H PVEG FCIC TSXV:MUST.H BOM:531930 USAQ EZCL TSXV:MCN RLBY TSXV:GCCC ETNI CHWE BOM:538568 TSXV:WT.H KLMN BOM:519319 BOM:508963 BOM:539762 TSXV:STR.H MTLK

Address 30 N Gould St, Suite R, Sheridan, WY, USA, 82801

Website https://www.inaiapp.com

Protect Pharmaceutical Corp is engaged in Textiles and Software as a Service.